LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP5 | 2 | D03 | 72 | hr | 1476 | 3003 | 3731 | 0.8048 | 0.7003 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP5 | 3 | D03 | 72 | hr | 1476 | 2984 | 3796 | 0.7860 | 0.6759 |
| SK-BR-3 | Dasatinib | 3.33 | uM | LJP6 | 1 | I02 | 72 | hr | 1476 | 1921 | 3413 | 0.5628 | 0.2431 |
| SK-BR-3 | Dasatinib | 3.33 | uM | LJP6 | 2 | I02 | 72 | hr | 1476 | 2063 | 3783 | 0.5453 | 0.2793 |
| SK-BR-3 | Dasatinib | 3.33 | uM | LJP6 | 3 | I02 | 72 | hr | 1476 | 1907 | 3734 | 0.5107 | 0.2105 |
| SK-BR-3 | Dasatinib | 3.33 | uM | LJP5 | 1 | D02 | 72 | hr | 1476 | 2165 | 3788 | 0.5714 | 0.3251 |
| SK-BR-3 | Dasatinib | 3.33 | uM | LJP5 | 2 | D02 | 72 | hr | 1476 | 2081 | 3731 | 0.5577 | 0.2924 |
| SK-BR-3 | Dasatinib | 3.33 | uM | LJP5 | 3 | D02 | 72 | hr | 1476 | 2113 | 3796 | 0.5565 | 0.3008 |
| SK-BR-3 | Dasatinib | 10 | uM | LJP6 | 1 | I01 | 72 | hr | 1476 | 832 | 3413 | 0.2438 | -0.3779 |
| SK-BR-3 | Dasatinib | 10 | uM | LJP6 | 2 | I01 | 72 | hr | 1476 | 933 | 3783 | 0.2466 | -0.2870 |
| SK-BR-3 | Dasatinib | 10 | uM | LJP6 | 3 | I01 | 72 | hr | 1476 | 879 | 3734 | 0.2354 | -0.3213 |
| SK-BR-3 | Dasatinib | 10 | uM | LJP5 | 1 | D01 | 72 | hr | 1476 | 1207 | 3788 | 0.3186 | -0.1379 |
| SK-BR-3 | Dasatinib | 10 | uM | LJP5 | 2 | D01 | 72 | hr | 1476 | 1279 | 3731 | 0.3428 | -0.1019 |
| SK-BR-3 | Dasatinib | 10 | uM | LJP5 | 3 | D01 | 72 | hr | 1476 | 1179 | 3796 | 0.3105 | -0.1523 |
| SK-BR-3 | Tozasertib | 0.04 | uM | LJP5 | 1 | B18 | 72 | hr | 1476 | 1176 | 3788 | 0.3104 | -0.1542 |
| SK-BR-3 | Tozasertib | 0.04 | uM | LJP5 | 2 | B18 | 72 | hr | 1476 | 1291 | 3731 | 0.3460 | -0.0956 |
| SK-BR-3 | Tozasertib | 0.04 | uM | LJP5 | 3 | B18 | 72 | hr | 1476 | 1135 | 3796 | 0.2990 | -0.1757 |
| SK-BR-3 | Tozasertib | 0.12 | uM | LJP5 | 1 | B17 | 72 | hr | 1476 | 1277 | 3788 | 0.3371 | -0.1014 |
| SK-BR-3 | Tozasertib | 0.12 | uM | LJP5 | 2 | B17 | 72 | hr | 1476 | 1245 | 3731 | 0.3337 | -0.1198 |
| SK-BR-3 | Tozasertib | 0.12 | uM | LJP5 | 3 | B17 | 72 | hr | 1476 | 1238 | 3796 | 0.3261 | -0.1214 |
| SK-BR-3 | Tozasertib | 0.37 | uM | LJP5 | 1 | B16 | 72 | hr | 1476 | 1305 | 3788 | 0.3445 | -0.0869 |
| SK-BR-3 | Tozasertib | 0.37 | uM | LJP5 | 2 | B16 | 72 | hr | 1476 | 1182 | 3731 | 0.3168 | -0.1534 |
| SK-BR-3 | Tozasertib | 0.37 | uM | LJP5 | 3 | B16 | 72 | hr | 1476 | 1223 | 3796 | 0.3221 | -0.1292 |
| SK-BR-3 | Tozasertib | 1.11 | uM | LJP5 | 1 | B15 | 72 | hr | 1476 | 1298 | 3788 | 0.3426 | -0.0905 |
| SK-BR-3 | Tozasertib | 1.11 | uM | LJP5 | 2 | B15 | 72 | hr | 1476 | 1317 | 3731 | 0.3530 | -0.0820 |